[Webinar] MoveDMD Trial Open-Label Extension Results

Event Details

[Webinar] MoveDMD Trial Open-Label Extension Results

Time: October 4, 2017 from 6pm to 7pm
Location: Online Webinar - Eastern Time Zone
Event Type: webinar
Organized By: PPMD
Latest Activity: Oct 4, 2017

Export to Outlook or iCal (.ics)

Event Description

Please join Parent Project Muscular Dystrophy and Catabasis Pharmaceuticals as we host a webinar Wednesday, October 11 at 1:00 PM EDT to hear a community update on the results from the open-label extension of the MoveDMD trial following 24 and 36 weeks of edasalonexent treatment in boys with Duchenne muscular dystrophy.



  • Pat Furlong
    Founding President & CEO, Parent Project Muscular Dystrophy


  • Joanne M. Donovan, M.D., Ph.D.
    Chief Medical Officer, Catabasis Pharmaceuticals
    Dr. Joanne Donovan is the Chief Medical Officer of Catabasis Pharmaceuticals, Inc. She received her academic training at MIT, Harvard and Brigham & Women’s Hospital and has more than 15 years of experience in drug development taking programs from Phase 1 to approval. Dr. Donovan is currently Associate Clinical Professor of Medicine at Harvard and continues to practice and teach medicine.

To Participate:

View call-in information & pre-register to receive a reminder email for this webinar.

Submit Questions:

Please submit questions in advance to info@parentprojectmd.org (subject line: Catabasis Webinar) by Monday, October 9th at 12:00 PM ET.

Comment Wall


RSVP for [Webinar] MoveDMD Trial Open-Label Extension Results to add comments!

Join PPMD Community

Attending (1)

Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service